This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Sat.Mar 23, 2024

article thumbnail

#ScienceSaturday: March 23, 2024

KIF1A

MARCH 23, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Whole exome sequencing in Serbian patients with hereditary spastic paraplegia This year we’ve seen several studies investigating the genetics of hereditary spastic paraplegia (HSP), an umbr

FDA Approval 105
FDA Approval Therapies FDA Disease 105
article thumbnail

Stem cell model offers first glimpse of early human embryonic development

Science Daily: Pharmacology News

MARCH 23, 2024

The new platform's ethically grounded approach promises to reveal much about how human embryos form during the earliest stages of pregnancy.

96
96
article thumbnail

Which pharmaceutical companies have the most SPCs in Romania?

Drug Patent Watch

MARCH 23, 2024

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania.

Pharmaceutical Companies 52
Pharmaceutical Companies Pharmaceuticals 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 15,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024